PURPOSE: Sickle cell disease is estimated to occur in 1:300-400 African-American births, with higher rates among immigrants from Africa and the Caribbean, and is less common among Hispanic births. This study determined sickle cell disease incidence among New York State newborns stratified by maternal race/ethnicity and nativity. METHODS: Newborns with confirmed sickle cell disease born to New York State residents were identified by the New York State newborn screening program for the years 2000-2008 and matched to birth records to obtain birth and maternal information. Annual incidence rates were computed and bivariate analyses were conducted to examine associations with maternal race/ethnicity and nativity. RESULTS: From 2000 to 2008, 1,911 New York State newborns were diagnosed with sickle cell disease and matched to the birth certificate files. One in every 1,146 live births was diagnosed with sickle cell disease. Newborns of non-Hispanic black mothers accounted for 86% of sickle cell disease cases whereas newborns of Hispanic mothers accounted for 12% of cases. The estimated incidence was 1:230 live births for non-Hispanic black mothers, 1:2,320 births for Hispanic mothers, and 1:41,647 births for non-Hispanic white mothers. Newborns of foreign-born non-Hispanic black mothers had a twofold higher incidence of sickle cell disease than those born to US-born non-Hispanic black mothers (P < 0.001). CONCLUSION: This study provides the first US estimates of sickle cell disease incidence by maternal nativity. Women born outside the United States account for the majority of children with sickle cell disease born in New York State. Such findings identify at-risk populations and inform outreach activities that promote ongoing, high-quality medical management to affected children.
PURPOSE: Sickle cell disease is estimated to occur in 1:300-400 African-American births, with higher rates among immigrants from Africa and the Caribbean, and is less common among Hispanic births. This study determined sickle cell disease incidence among New York State newborns stratified by maternal race/ethnicity and nativity. METHODS: Newborns with confirmed sickle cell disease born to New York State residents were identified by the New York State newborn screening program for the years 2000-2008 and matched to birth records to obtain birth and maternal information. Annual incidence rates were computed and bivariate analyses were conducted to examine associations with maternal race/ethnicity and nativity. RESULTS: From 2000 to 2008, 1,911 New York State newborns were diagnosed with sickle cell disease and matched to the birth certificate files. One in every 1,146 live births was diagnosed with sickle cell disease. Newborns of non-Hispanic black mothers accounted for 86% of sickle cell disease cases whereas newborns of Hispanic mothers accounted for 12% of cases. The estimated incidence was 1:230 live births for non-Hispanic black mothers, 1:2,320 births for Hispanic mothers, and 1:41,647 births for non-Hispanic white mothers. Newborns of foreign-born non-Hispanic black mothers had a twofold higher incidence of sickle cell disease than those born to US-born non-Hispanic black mothers (P < 0.001). CONCLUSION: This study provides the first US estimates of sickle cell disease incidence by maternal nativity. Women born outside the United States account for the majority of children with sickle cell disease born in New York State. Such findings identify at-risk populations and inform outreach activities that promote ongoing, high-quality medical management to affected children.
Authors: Violanda Grigorescu; Mary J Kleyn; Steven J Korzeniewski; William I Young; Wanda Whitten-Shurney Journal: Am J Prev Med Date: 2010-04 Impact factor: 5.043
Authors: Saira Siddiqui; Kelly Schunk; Milagros Batista; Francisca Adames; Peggy Ayala; Benjamin Stix; Jacqueline Rodriguez; Mary McCord; Nancy S Green Journal: J Urban Health Date: 2012-02 Impact factor: 3.671
Authors: A A Herman; B J McCarthy; J M Bakewell; R H Ward; B A Mueller; N E Maconochie; A W Read; P Zadka; R Skjaerven Journal: Paediatr Perinat Epidemiol Date: 1997-01 Impact factor: 3.980
Authors: Antonio G Pacheco; Valeria Saraceni; Suely H Tuboi; Lawrence H Moulton; Richard E Chaisson; Solange C Cavalcante; Betina Durovni; José C Faulhaber; Jonathan E Golub; Bonnie King; Mauro Schechter; Lee H Harrison Journal: Am J Epidemiol Date: 2008-10-09 Impact factor: 4.897
Authors: Cristina R Fernández; Maureen Licursi; Randi Wolf; Margaret T Lee; Nancy S Green Journal: Pediatr Blood Cancer Date: 2021-11-22 Impact factor: 3.167
Authors: Marci K Sontag; Careema Yusuf; Scott D Grosse; Sari Edelman; Joshua I Miller; Sarah McKasson; Yvonne Kellar-Guenther; Marcus Gaffney; Cynthia F Hinton; Carla Cuthbert; Sikha Singh; Jelili Ojodu; Stuart K Shapira Journal: MMWR Morb Mortal Wkly Rep Date: 2020-09-11 Impact factor: 17.586
Authors: Ying Wang; Gang Liu; Michele Caggana; Joseph Kennedy; Regina Zimmerman; Suzette O Oyeku; Ellen M Werner; Althea M Grant; Nancy S Green; Scott D Grosse Journal: Genet Med Date: 2014-09-25 Impact factor: 8.822
Authors: Seth S Leopold; Lee Beadling; Anthony M Calabro; Matthew B Dobbs; Mark C Gebhardt; Terence J Gioe; Paul A Manner; Raphaël Porcher; Clare M Rimnac; Montri D Wongworawat Journal: Clin Orthop Relat Res Date: 2018-05 Impact factor: 4.176
Authors: Shelly-Ann Williams; Beneka Browne-Ferdinand; Ynolde Smart; Kristen Morella; Susan G Reed; Julie Kanter Journal: Glob Pediatr Health Date: 2017-11-03
Authors: Angela B Snyder; Mei Zhou; Rodney Theodore; Maa-Ohui Quarmyne; James Eckman; Peter A Lane Journal: Public Health Rep Date: 2019-04-10 Impact factor: 2.792
Authors: Christopher S Parker; James Tsai; Azfar-e-Alam Siddiqi; Hani K Atrash; Lisa C Richardson Journal: Am J Prev Med Date: 2014-09-19 Impact factor: 5.043